NCT04161131View on ClinicalTrials.gov

Overcoming Barriers and Obstacles to Adopting Diabetes Devices

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 9, 2019

Primary Completion Date

October 22, 2020

Study Completion Date

October 22, 2020

Conditions
Type 1 Diabetes
Interventions
BEHAVIORAL

ONBOARD

Session 1: Overview; Overcoming Physical Barriers (experiential wear) Session 2: Managing CGM data (cognitive restructuring) Session 3: Social barriers (problem solving) Session 4: Trust in CGM (motivational interviewing, review of prior sessions)

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Molly Tanenbaum

OTHER

NCT04161131 - Overcoming Barriers and Obstacles to Adopting Diabetes Devices | Biotech Hunter | Biotech Hunter